TotalAssist Myasthenia Gravis Fund

TotalAssist Myasthenia Gravis Fund is sponsored by Patient Advocate Foundation (PAF). Launching July 1, 2026, the TotalAssist program will offer grants to help people living with myasthenia gravis pay for a comprehensive set of eligible out-of-pocket healthcare expenses.

TotalAssist program - Patient Advocate Foundation Launching on July 1, 2026, TotalAssist is a major step forward in how patient assistance works: simple, flexible, and centered on real-world patient needs.

List of TotalAssist funds TotalAssist is the nation’s largest and most comprehensive charitable patient assistance portfolio On July 1, 2026, Patient Advocate Foundation launches TotalAssist—a unified financial assistance program designed to make it easier for patients to start and stay on treatment.

By bringing together the strengths of Patient Advocate Foundation and PAN Foundation, TotalAssist is a major step forward in how patient assistance works: simple, flexible, and centered on real-world patient needs. TotalAssist is the nation’s largest and most comprehensive charitable patient assistance portfolio.

At launch, it includes nearly 150 disease-specific and health equity financial assistance funds, supporting patients across a wide range of conditions—from cancer and rare diseases to chronic and complex illnesses.

TotalAssist helps patients pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, office visit charges the day of treatment, and administration charges related to treatment. TotalAssist does not limit how grants can be used. Instead, TotalAssist allows patients to apply their grant toward multiple healthcare expenses, helping reduce gaps in care.

Through our TotalAssist program, patients may use grants for: Medication copays, coinsurance, and deductibles Health insurance premiums Office visit charges the day of treatment Administration charges related to treatment This comprehensive approach reflects how patients actually experience care—and helps remove the financial barriers that too often interrupt treatment.

At a time when healthcare costs continue to rise and more people are struggling to afford care, TotalAssist expands access, reduces complexity, and strengthens the safety net for patients nationwide.

Broad and reliable coverage Nearly 150 disease-specific funds covering high-need conditions nationwide Use of grants to cover more eligible out-of-pocket healthcare costs: medication copays, coinsurance, and deductibles, health insurance premiums, office visit charges the day of treatment, and administration charges related to treatment Financial assistance for treatments that are FDA-approved, listed in official compendia, and published in evidence-based guidelines Guaranteed grant amounts, with additional support provided automatically when available No waitlists and first-come, first-served enrollment Instant eligibility decisions at the time of application Simplifying the patient journey Simple online portals for patients, healthcare professionals, pharmacies, and nonprofits Diagnosis verification handled directly with providers—reducing burden on patients Streamlined medical claims, insurance premiums, and patient reimbursements: All processed in-house and can be easily uploaded via the portal Point of sale pharmacy claims processing: Pharmacy claims are processed at the point of sale through a virtual pharmacy card, making it easy for both patients and pharmacies Putting patients at the center TotalAssist is designed to address patient realities and not add administrative complexity.

Key patient-focused features include: Six-month lookback coverage, allowing eligible patients to apply assistance to qualifying expenses incurred before enrollment Dedicated patient support specialists to guide patients and caregivers through enrollment Concierge support to onboard and support providers and pharmacies Patients also benefit from trusted tools like FundFinder , which helps identify alternative assistance when funds are unavailable, and the National Financial Resource Directory , which connects people to additional support beyond healthcare costs.

Get updates on our journey Get updates on our journey Patient Advocate Foundation pioneered health equity funds to ensure assistance reaches the people and communities who need it most. TotalAssist will include over 20 health equity funds, serving patients in hundreds of counties across dozens of states identified through a data-driven methodology using the CDC’s Social Vulnerability Index and disease incidence data.

Eligibility for health equity funds is determined by zip code, with all other requirements consistent with standard disease funds, helping reduce disparities while maintaining fairness and transparency. Below is the list of funds that will be included at the TotalAssist launch on July 1, 2026.

As needs continue to evolve, the funds offered through TotalAssist will continue to grow, expanding support where gaps exist and ensuring assistance remains responsive to patients nationwide. When TotalAssist launches on July 1, 2026, fund eligibility may change with patient access in mind. We will continue to update this page and our help center as information is released.

Fund name Maximum award amount Insurance type Percentage FPL Acromegaly $5,000 Government Insured 500 Acute Lymphoblastic Leukemia $9,000 All Insurances 500 Acute Myeloid Leukemia (AML) $8,600 Government Insured 500 Alzheimer’s Disease Health Equity $3,500 Government Insured 500 Amyloidosis $5,500 Government Insured 500 Ankylosing Spondylitis (AS) $4,400 Government Insured 500 Asthma $3,500 Government Insured 500 Asthma Health Equity $3,500 Government Insured 500 Atopic Dermatitis $4,200 Government Insured 500 Basal Cell Carcinoma $4,600 All Insurances 500 Biliary Tract Cancer (BTC) $6,200 Government Insured 500 Bipolar Disorder $4,400 Government Insured 500 Bladder Cancer $6,500 Government Insured 500 Breast Cancer $6,500 All Insurances 500 Breast Cancer Health Equity $6,500 All Insurances 500 Cancer Genetic and Genomic Testing $250 All Insurances 500 Cardiomyopathy $2,000 Government Insured 500 Cervical Cancer $4,000 All Insurances 500 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) $9,500 Government Insured 500 Chronic Kidney Disease (CKD) $4,800 Government Insured 500 Chronic Lymphocytic Leukemia (CLL) $9,500 All Insurances 500 Chronic Obstructive Pulmonary Disease (COPD) $3,500 Government Insured 500 Chronic Obstructive Pulmonary Disease (COPD) Health Equity $3,500 Government Insured 500 Chronic Spontaneous Urticaria (CSU) $5,200 All Insurances 500 Colorectal Cancer $5,000 Government Insured 500 Coronary Artery Disease (CAD) Health Equity $1,500 Government Insured 500 COVID-19 & Post COVID $2,300 All Insurances 500 Cushing’s Disease or Syndrome $9,500 All Insurances 500 Cystic Fibrosis (CF) $5,000 All Insurances 500 Dermatomyosis $9,000 All Insurances 500 Diabetic Macular Edema (DME) $4,500 Government Insured 500 Diabetic Retinopathy (DR) $4,500 Government Insured 500 Diffuse Large B-cell Lymphoma (DLBCL) $6,400 All Insurances 500 Duchenne Muscular Dystrophy (DMD) $15,400 All Insurances 500 Eosinophilic Esophagitis $2,000 Government Insured 500 Eosinophilic Granulomatosis with Polyangiitis $7,400 All Insurances 500 Fabry Disease $9,000 All Insurances 500 Fabry Disease Health Equity $9,000 All Insurances 500 Follicular Lymphoma $7,400 Government Insured 500 Gastrointestinal Stromal Tumors (GIST) $4,200 Government Insured 500 Gaucher Disease $14,000 All Insurances 500 Gaucher Disease Health Equity $14,000 All Insurances 500 Glioblastoma Multiforme (GBM) $3,800 All Insurances 500 Graft vs Host Disease (GvHD) $9,500 All Insurances 500 Growth Hormone Deficiency $10,000 All Insurances 500 Heart Failure $2,500 Government Insured 500 Heart Failure Health Equity $2,500 Government Insured 500 Hemolytic Uremic Syndrome (HUS) $9,500 All Insurances 500 Hemophilia $12,500 All Insurances 500 Hemophilia Health Equity $12,500 All Insurances 500 Hepatitis B (HepB) $3,000 All Insurances 500 Hepatitis B (HepB) Health Equity $3,000 All Insurances 500 Hepatitis C (HepC) $6,000 All Insurances 500 Hepatitis C (HepC) Health Equity $6,000 All Insurances 500 HIV, AIDS, and Prevention $5,000 All Insurances 500 HIV, AIDS, and Prevention Health Equity $5,000 All Insurances 500 Hypercholesterolemia $3,800 Government Insured 500 Hyperkalemia $3,600 Government Insured 500 Hypertrophic Cardiomyopathy $7,200 All Insurances 500 Hypophosphatasia $9,500 All Insurances 500 Immune Thrombocytopenic Purpura (ITP) $10,000 Government Insured 500 Inflammatory Bowel Disease (IBD) $10,400 Government Insured 500 Inherited Retinal Disease (IRD) $8,600 All Insurances 500 Lipodystrophy $4,000 All Insurances 500 Liver Cancer $7,600 Government Insured 500 Long-chain fatty acid oxidation disorders (LC-FAOD) $11,800 All Insurances 500 Lupus $4,500 Government Insured 500 Lupus Health Equity $4,500 Government Insured 500 Lysosomal Acid Lipase Deficiency (LAL-D) $9,500 All Insurances 500 Fund name Maximum fund amount Insurance type Percentage FPL Macular Degeneration and Related Diseases $4,600 Government Insured 500 Mantle Cell Lymphoma (MCL) $5,000 Government Insured 500 Melanoma $10,000 Government Insured 500 Metabolic dysfunction-associated steatohepatitis (MASH) $4,200 Government Insured 500 Metastatic Breast Cancer $7,000 All Insurances 500 Metastatic Colorectal Cancer $6,000 Government Insured 500 Metastatic Colorectal Cancer Health Equity $6,000 Government Insured 500 Metastatic Gastric Cancer $8,000 All Insurances 500 Metastatic Melanoma $10,000 Government Insured 500 Metastatic Prostate Cancer $6,000 Government Insured 500 Mucopolysaccharidosis Type III (MPSIII) $2,500 All Insurances 500 Mucopolysaccharidosis Type VII (MPSVII) $7,500 All Insurances 500 Mucopolysaccharidosis Type VII (MPSVII) Health Equity $7,500 All Insurances 500 Multiple Myeloma $10,000 Government Insured 500 Multiple Myeloma Health Equity $10,000 Government Insured 500 Multiple Sclerosis (MS) $8,000 Government Insured 500 Multiple Sclerosis (MS) Health Equity $8,000 Government Insured 500 Myasthenia Gravis (MG) $10,000 Government Insured 500 Myelodysplastic Syndromes (MDS) $8,000 Government Insured 500 Narcolepsy $5,000 All Insurances 500 Neurofibromatosis (NF) $6,400 All Insurances 500 Neuromyelitis Optica Spectrum Disorder (NMOSD) $8,000 All Insurances 500 Neurotrophic Keratitis (NK) $8,000 Government Insured 500 Neutropenia $4,400 Government Insured 500 Non-Hodgkin’s Lymphoma (NHL) $7,200 Government Insured 500 Non-Small Cell Lung Cancer (NSCLC) $6,000 Government Insured 500 Non-Small Cell Lung Cancer (NSCLC) Health Equity $6,000 Government Insured 500 Obesity $2,000 All Insurances 300 Osteoporosis $2,500 Government Insured 500 Ovarian Cancer $4,000 Government Insured 500 Ovarian Cancer Health Equity $4,000 Government Insured 500 Pancreatic Cancer $6,000 Government Insured 500 Parkinson’s Disease $4,400 Government Insured 500 Parkinson’s Disease Health Equity $4,400 Government Insured 500 Paroxysmal Nocturnal Hemoglobinuria (PNH) $9,500 All Insurances 500 Pemphigus Vulgaris (PV) $14,600 Government Insured 500 Periodic Paralysis $1,500 All Insurances 500 Peripheral Vascular and Artery Disease $1,500 Government Insured 500 Philadelphia Chromosome Negative Myeloproliferative Neoplasms $9,500 All Insurances 500 Pompe Disease $9,500 All Insurances 500 Pompe Disease Health Equity $9,500 All Insurances 500 Primary Biliary Cholangitis (PBC) $2,500 Government Insured 500 Prostate Cancer $4,000 Government Insured 500 Prostate Cancer Health Equity $4,000 Government Insured 500 Psoriasis $2,500 Government Insured 500 Psoriatic Arthritis $3,500 Government Insured 500 Pulmonary Fibrosis $7,000 Government Insured 500 Pulmonary Hypertension $9,500 All Insurances 500 Renal Cell Carcinoma (RCC) $8,000 Government Insured 500 Retinal Vein Occlusion (RVO) $4,600 Government Insured 500 Rett Syndrome (RS) $4,400 All Insurances 500 Rheumatoid Arthritis $4,000 Government Insured 500 Schizophrenia $4,200 Government Insured 500 Short Bowel Syndrome (SBS) $9,800 All Insurances 500 Sickle Cell Disease $5,600 Government Insured 500 Skin Cancer $6,000 Government Insured 500 Small Cell Lung Cancer (SCLC) $8,500 Government Insured 500 Social Needs Assessment & Intervention $300 All Insurances 500 Soft Tissue Sarcoma $5,000 Government Insured 500 Solid Organ Transplant Preservation and Rejection Prevention $9,000 All Insurances 500 Spinal Muscular Atrophy $6,500 All Insurances 500 Spinal Muscular Atrophy Health Equity $6,500 All Insurances 500 Stroke $1,500 Government Insured 500 Thyroid Cancer $8,200 Government Insured 500 Thyroid Eye Disease (TED) $9,000 All Insurances 500 Transportation $500 All Insurances 500 Type 2 Diabetes (T2DM) $2,000 Government Insured 500 Type 2 Diabetes (T2DM) Health Equity $2,000 Government Insured 500 Ulcerative Colitis $3,000 Government Insured 500 Uterine Cancer $6,000 Government Insured 500 Uterine Cancer Health Equity $6,000 Government Insured 500 Uveitis $1,400 All Insurances 500 Virology Testing Health Equity $250 All Insurances 500 Von Willebrand Disease (vWD) $17,600 All Insurances 500 Waldenstrom Macroglobulinemia $9,500 All Insurances 500 Wilson’s Disease $9,000 All Insurances 500 Use our help center to find answers to questions that impact you.

Reach out with any questions or concerns. We will get in touch with you as quickly as possible.